162 related articles for article (PubMed ID: 20494369)
1. The Swedish reflux trial in children: IV. Renal damage.
Brandström P; Nevéus T; Sixt R; Stokland E; Jodal U; Hansson S
J Urol; 2010 Jul; 184(1):292-7. PubMed ID: 20494369
[TBL] [Abstract][Full Text] [Related]
2. The Swedish reflux trial in children: III. Urinary tract infection pattern.
Brandström P; Esbjörner E; Herthelius M; Swerkersson S; Jodal U; Hansson S
J Urol; 2010 Jul; 184(1):286-91. PubMed ID: 20488494
[TBL] [Abstract][Full Text] [Related]
3. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.
Swerkersson S; Jodal U; Sixt R; Stokland E; Hansson S
J Urol; 2007 Aug; 178(2):647-51; discussion 650-1. PubMed ID: 17574623
[TBL] [Abstract][Full Text] [Related]
4. The Swedish reflux trial in children: v. Bladder dysfunction.
Sillén U; Brandström P; Jodal U; Holmdahl G; Sandin A; Sjöberg I; Hansson S
J Urol; 2010 Jul; 184(1):298-304. PubMed ID: 20488486
[TBL] [Abstract][Full Text] [Related]
5. The Swedish reflux trial in children: I. Study design and study population characteristics.
Brandström P; Esbjörner E; Herthelius M; Holmdahl G; Läckgren G; Nevéus T; Sillén U; Sixt R; Sjöberg I; Stokland E; Jodal U; Hansson S
J Urol; 2010 Jul; 184(1):274-9. PubMed ID: 20478580
[TBL] [Abstract][Full Text] [Related]
6. High grade primary vesicoureteral reflux in boys: long-term results of a prospective cohort study.
Alsaywid BS; Saleh H; Deshpande A; Howman-Giles R; Smith GH
J Urol; 2010 Oct; 184(4 Suppl):1598-603. PubMed ID: 20728178
[TBL] [Abstract][Full Text] [Related]
7. Impact of micturating cystourethrography and DMSA renal scintigraphy on the investigation scheme in children with urinary tract infection.
Ajdinović B; Jauković L; Krstić Z; Dopuda M
Ann Nucl Med; 2008 Oct; 22(8):661-5. PubMed ID: 18982468
[TBL] [Abstract][Full Text] [Related]
8. The Swedish infant high-grade reflux trial: UTI and renal damage.
Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
[TBL] [Abstract][Full Text] [Related]
9. Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.
Leslie B; Moore K; Salle JL; Khoury AE; Cook A; Braga LH; Bägli DJ; Lorenzo AJ
J Urol; 2010 Sep; 184(3):1093-8. PubMed ID: 20650501
[TBL] [Abstract][Full Text] [Related]
10. The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux.
Brandström P; Jodal U; Sillén U; Hansson S
J Pediatr Urol; 2011 Dec; 7(6):594-600. PubMed ID: 21807562
[TBL] [Abstract][Full Text] [Related]
11. Predicting early recurrent urinary tract infection in pretoilet trained children with vesicoureteral reflux.
Yamazaki Y; Shiroyanagi Y; Matsuno D; Nishi M
J Urol; 2009 Oct; 182(4 Suppl):1699-702. PubMed ID: 19692080
[TBL] [Abstract][Full Text] [Related]
12. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome.
Holmdahl G; Brandström P; Läckgren G; Sillén U; Stokland E; Jodal U; Hansson S
J Urol; 2010 Jul; 184(1):280-5. PubMed ID: 20488469
[TBL] [Abstract][Full Text] [Related]
13. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.
Chertin B; Natsheh A; Fridmans A; Shenfeld OZ; Farkas A
J Urol; 2009 Oct; 182(4 Suppl):1703-6. PubMed ID: 19692032
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment.
Steinhardt GF
J Urol; 2010 Jul; 184(1):296-7. PubMed ID: 20494371
[No Abstract] [Full Text] [Related]
15. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.
Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S
J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial.
Montini G; Rigon L; Zucchetta P; Fregonese F; Toffolo A; Gobber D; Cecchin D; Pavanello L; Molinari PP; Maschio F; Zanchetta S; Cassar W; Casadio L; Crivellaro C; Fortunati P; Corsini A; Calderan A; Comacchio S; Tommasi L; Hewitt IK; Da Dalt L; Zacchello G; Dall'Amico R;
Pediatrics; 2008 Nov; 122(5):1064-71. PubMed ID: 18977988
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for breakthrough infection in children with primary vesicoureteral reflux.
Shiraishi K; Yoshino K; Watanabe M; Matsuyama H; Tanikaze S
J Urol; 2010 Apr; 183(4):1527-31. PubMed ID: 20172558
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal development of renal damage and renal function in infants with high grade vesicoureteral reflux.
Sjöström S; Jodal U; Sixt R; Bachelard M; Sillén U
J Urol; 2009 May; 181(5):2277-83. PubMed ID: 19303099
[TBL] [Abstract][Full Text] [Related]
19. Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.
Moriya K; Mitsui T; Kitta T; Nakamura M; Kanno Y; Kon M; Nishimura Y; Shinohara N; Nonomura K
J Urol; 2015 Feb; 193(2):637-42. PubMed ID: 25111912
[TBL] [Abstract][Full Text] [Related]
20. Renal parenchymal damage in male infants with high grade vesicoureteral reflux diagnosed after the first urinary tract infection.
Cascio S; Chertin B; Colhoun E; Puri P
J Urol; 2002 Oct; 168(4 Pt 2):1708-10; discussion 1710. PubMed ID: 12352340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]